International Clinical Trial: Study on the Application of Quantitative Detection of Feto-Maternal Hemorrhage in the Diagnosis of Hemolytic Disease of the Newborn

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119509) titled 'Study on the Application of Quantitative Detection of Feto-Maternal Hemorrhage in the Diagnosis of Hemolytic Disease of the Newborn' on Feb. 28.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Shanghai General Hospital

Condition: Hemolytic Disease of the Newborn

Intervention: Fetomaternal hemorrhage (FMH) values >= 0.5%

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-01

Target Sample Size: Fetomaternal hemorrhage (FMH) values >= 0.5%;Fetomaternal hemorrhage (FMH) value < 0.5%:100;

Countries of Recruitment: China

To know more, visit http...